Medpace Holdings (MEDP) Shares Outstanding (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Shares Outstanding (Entity) came in at $27.9 million in Q2 2026, down 0.63% on a YoY basis from $28.1 million in Q2 2025, and down 2.27% quarter-over-quarter from $28.6 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Shares Outstanding (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Shares Outstanding (Entity) for 12 consecutive years, with $27.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Entity) fell 0.63% year-over-year to $27.9 million; the trailing twelve-month figure through Jun 2026 stood at $27.9 million (down 0.63% YoY), and the FY2025 full-year result was $28.4 million, down 7.38% from the prior year.
- Shares Outstanding (Entity) retreated to $27.9 million in Q2 2026 per MEDP's latest filing, from $28.6 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $33.7 million in Q1 2022 and bottomed at $27.9 million in Q2 2026.
- Historically, Shares Outstanding (Entity) has averaged $30.2 million across 5 years, with a median of $30.7 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) dropped 13.65% in 2022, then increased 1.44% in 2024.
- Over 5 years, Shares Outstanding (Entity) stood at $31.1 million in 2022, then declined by 1.09% to $30.8 million in 2023, then retreated by 0.4% to $30.6 million in 2024, then declined by 7.38% to $28.4 million in 2025, then decreased by 1.62% to $27.9 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $27.9 million, $28.6 million, and $28.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 166.10 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 28.17 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 78.42 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 48.02 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 94.80 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 355.16 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 62.09 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 13.90 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 46.38 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 5.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.17 Mn |
| Mar 31, 2026 | 28.45 Mn |
| Dec 31, 2025 | 28.85 Mn |
| Sep 30, 2025 | 28.14 Mn |
| Jun 30, 2025 | 28.60 Mn |
| Mar 31, 2025 | 30.39 Mn |
| Dec 31, 2024 | 30.96 Mn |
| Sep 30, 2024 | 31.05 Mn |
| Jun 30, 2024 | 30.99 Mn |
| Mar 31, 2024 | 30.84 Mn |
| Dec 31, 2023 | 30.72 Mn |
| Sep 30, 2023 | 30.63 Mn |
| Jun 30, 2023 | 30.54 Mn |
| Mar 31, 2023 | 31.01 Mn |
| Dec 31, 2022 | 32.39 Mn |
| Sep 30, 2022 | 31.01 Mn |
| Jun 30, 2022 | 32.49 Mn |
| Mar 31, 2022 | 34.92 Mn |
| Dec 31, 2021 | 35.86 Mn |
| Sep 30, 2021 | 35.82 Mn |